In 2008, a hepatocellular carcinoma (HCC) pilot-study was published, showing that the levels of endothelial (CD31+/CD42-) and hepatocyte (HepPar) derived MPs in HCC liver transplant patients were altered after surgery and correlated with the clinical outcome (37). This evidence concerns the gene PECAM1 and hepatocellular carcinoma.